Literature DB >> 20081742

Chemoradiotherapy: its effectiveness, toxicity, and perspective in the treatment of esophageal cancer.

Harushi Udagawa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20081742

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


× No keyword cloud information.
  4 in total

1.  Treatment outcome and prognosis of patients with lymph node recurrence of thoracic esophageal squamous cell carcinoma after curative resection.

Authors:  Toshiyuki Kosuga; Atsushi Shiozaki; Hitoshi Fujiwara; Daisuke Ichikawa; Kazuma Okamoto; Shuhei Komatsu; Eigo Otsuji
Journal:  World J Surg       Date:  2011-04       Impact factor: 3.352

2.  A case of synchronous squamous cell carcinoma in the esophagus and stomach.

Authors:  Sun Min Lim; Eun Suk Jung; Sung Kwan Shin; Hyun Soo Chung; Hyung Il Kim; Do Whan Kim; Byoung Chul Cho
Journal:  Gut Liver       Date:  2012-01-12       Impact factor: 4.519

3.  Second-line docetaxel-based chemotherapy after failure of fluorouracil-based first-line treatment for advanced esophageal squamous cell carcinoma.

Authors:  Zhengbo Song; Yiping Zhang
Journal:  Onco Targets Ther       Date:  2014-10-13       Impact factor: 4.147

4.  Personalized Kampo Medicine Facilitated Both Cytotoxic T Lymphocyte Response and Clinical Benefits Induced by Personalized Peptide Vaccination for Advanced Esophageal Cancer.

Authors:  Daisuke Muroya; Shigeru Yutani; Shigeki Shichijo; Akira Yamada; Shinjiro Sakamoto; Masayasu Naito; Koji Okuda; Michi Morita; Rin Yamaguchi; Kyogo Itoh
Journal:  Evid Based Complement Alternat Med       Date:  2016-09-15       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.